Fear of cancer recurrence: An overview and Australian perspective

Cancer Forum

Volumn 39, Issue 2, 2015, Pages 95-100

  Butow, Phyllis N ^a   Fardell, Joanna E ^a   Smith, Allan Ben ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACCEPTANCE AND COMMITMENT THERAPY; ANXIETY DISORDER; AUSTRALIAN; AUTOREGULATION; CANCER RECURRENCE; CANCER SURVIVOR; DISTRESS SYNDROME; EXECUTIVE FUNCTION; FAMILY; FEAR; HEALTH SERVICE; HUMAN; MISHEL UNCERTAINTY IN ILLNESS THEORY; QUALITY OF LIFE; REVIEW; SOCIETY;

EID: 84938153703     PISSN: 0311306X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. AIHW, AACR. Cancer in Australia: an overview, 2012. Canberra: AIHW; 2012
2. van den Beuken-van Everdingen MHJ, Peters ML, de Rijke JM, et al. Concerns of former breast cancer patients about disease recurrence: A validation and prevalence study. Psychooncology. 2008;17(11):1137-45
3. Vickberg SMJ. The concerns about recurrence scale (CARS): A systematic measure of women's fears about the possibility of breast cancer recurrence. Ann Behav Med. 2003;25(1):16-24
4. Lee-Jones C, Humphris G, Dixon R, et al. Fear of cancer recurrence-A literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology. 1997;6(2):95-105
5. Thewes B, Butow P, Zachariae R, et al. Fear of cancer recurrence: A systematic literature review of self-report measures. Psychooncology. 2012;21(6):571-87
6. Simard S, Savard J. Screening and comorbidity of clinical fear of cancer recurrence. Psychooncology. 2009;18(S2):171-2
7. Simard S, Savard J. Fear of Cancer Recurrence Inventory: Development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241-51
8. Herman S, Merckaert I, Lewis F, et al. Screening Dysfunctional Fear of Cancer Recurrence in Breast Cancer Patients Wishing for Psychological Help: The Validity of the Fear of Cancer Recurrence Inventory (FCRI). IPOS 15th World Congress of Psycho-Oncology; Rotterdam, the Netherlands 2013
9. Lebel S, Maheu C, Lefebvre M, et al. Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study. J Cancer Surviv. 2014
10. Northouse LL. Mastectomy patients and the fear of cancer recurrence. Cancer Nurs. 1981;4(3):213-20
11. Horowitz MJ, Wilner N, Alvarez W. Impact of Event Scale: A measure of subjective stress. Psychosom Med. 1979;41:209-18
12. Mellon S, Kershaw TS, Northouse LL, et al. A family-based model to predict fear of recurrence for cancer survivors and their caregivers. Psychooncology. 2007;16(3):214-23
13. Thewes B, Butow P, Bell ML, et al. Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Support Care Cancer. 2012;20(11):2651-9
14. Thewes B, Boyes A, Girgis A. Fear of cancer recurrence in the first year after diagnosis; Results of a registry based study. 12th World Congress of Internation Psycho-Oncology Society (IPOS); Quebec City, Quebec, Canada 2010
15. Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: A systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300-22
16. Koch L, Jansen L, Brenner H, et al. Fear of recurrence and disease progression in long-term (> 5years) cancer survivors-a systematic review of quantitative studies. Psychooncology. 2013;22(1):1-11
17. Herschbach P, Berg P, Dankert A, et al. Fear of progression in chronic diseases: Psychometric properties of the Fear of Progression Questionnaire. J Psychosom Res. 2005;58(6):505-11
18. Savard J, Ivers H. The evolution of fear of cancer recurrence during the cancer care trajectory and its relationship with cancer characteristics. J Psychosom Res. 2013;74(4):354-60.
19. Ghazali N, Cadwallader E, Lowe D, et al. Fear of recurrence among head and neck cancer survivors: Longitudinal trends. Psychooncology. 2013;22(4):807-13
20. Mast ME. Survivors of breast cancer: illness uncertainty, positive reappraisal, and emotional distress. Oncol Nurs Forum. 1998;25(3):555-62
21. Lebel S, Beattie S, Ares I, et al. Young and worried: Age and fear of recurrence in breast cancer survivors. Health Psychol. 2013;32(6):695-705
22. Arès I, Lebel S, Bielajew C. The impact of motherhood on perceived stress, illness intrusiveness and fear of cancer recurrence in young breast cancer survivors over time. Psychology and Health. 2014;29(6):651-70
23. Thewes B, Bell ML, Butow P, et al. Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: Results of a cross-sectional study. Psychooncology. 2013;22(12):2797-806
24. Crist J V, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: A systematic review. Psychooncology. In Press
25. Crist J V, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: A systematic review. Psychooncology. 2013;22(5):978-86
26. Persoskie A, Ferrer RA, Klein WM. Association of cancer worry and perceived risk with doctor avoidance: An analysis of information avoidance in a nationally representative us sample. J Behav Med. 2013 In press
27. Phillips KM, McGinty HL, Gonzalez BD, et al. Factors associated with breast cancer worry 3 years after completion of adjuvant treatment. Psychooncology. 2013;22(4):936-9
28. Simard S, Savard J, Ivers H. Fear of cancer recurrence: Specific profiles and nature of intrusive thoughts. J Cancer Surviv. 2010;4(4):361-71
29. Mehnert A, Berg P, Henrich G, et al. Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncology. 2009;18(12):1273-80
30. Cella DF, Mahon SM, Donovan MI. Cancer recurrence as a traumatic event. Behav Med. 1990;16(1):15-22
31. Kim Y, Carver CS, Spillers RL, et al. Dyadic effects of fear of recurrence on the quality of life of cancer survivors and their caregivers. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation. 2012;21(3):517-25
32. Maszczakiewicz E, Jolicoeur L, Lebel S, et al. Fear of recurrence and its effects on patient satisfaction with follow-up after primary therapy for endometrial cancer. Annual Scientific Meeting of the Canadian Association of Psychosocial Oncology; Vancouver, Canada. 2009
33. Lebel S, Tomei C, Feldstain A, et al. Does fear of cancer recurrence predict cancer survivors' health care use? Support Care Cancer. 2013;21(3):901-6
34. Hodgkinson K, Butow P, Hunt G, et al. The development and evaluation of a measure to assess cancer survivors' unmet supportive care needs: the CaSUN (Cancer Survivors' Unmet Needs measure). Psychooncology. 2007;16(9):796-804
35. Thewes B, Brebach R, Dzidowska M, et al. Current approaches to managing fear of cancer recurrence; a descriptive survey of psychosocial and clinical health professionals. Psychooncology. 2014;23(4):390-6
36. Mishel MH. Uncertainty in illness. Image J Nurs Sch. 1988;20(4):225-32
37. Mishel MH. Uncertainty in chronic illness. Annu Rev Nurs Res. 1999;17(1):269-94
38. Mishel MH, Germino BB, Gil KM, et al. Benefits from an uncertainty management intervention for African-American and Caucasian older longterm breast cancer survivors. Psychooncology. 2005;14(11):962-78
39. Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Cognitive Therapy and Research. 1992;16(2):143-63
40. Butow P, Bell M, Smith A, et al. Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence. BMC Cancer. 2013;13(1):201
41. Llewellyn C, Weinman J, McGurk M, et al. Can we predict which head and neck cancer survivors develop fears of cancer recurrence? J Psychosom Res. 2008;65:525-32
42. Easterling D V, Leventhal H. Contributions of concrete cognition to emotion: Neutral symptoms as elicitors of worry about cancer. J Appl Psychol. 1989;74(5):787-96
43. Hilton BA. The relationship of uncertainty, control, commitment, and threat of recurrence to coping strategies used by women diagnosed with breast cancer. J Behav Med. 1989;12(1):39-54
44. Wells A, Matthews G. Modelling cognition in emotional disorder: The S-REF model. Behaviour Research and Therapy. 1996;34(11-12):881-8
45. Cavanagh M, editor Attention training: towards a new effective treatment for hypochondriasis. 33rd Congress of the European Association of Behavioural and Cognitive Therapies; 2004; Manchester, UK
46. Cavanagh M, Franklin J. Attention Training and hypochondriasis: Preliminary results of a controlled treatment trial. World Congress of Cognitive and Behavioral Therapy; Vancouver, Canada. 2000
47. Wells A, Welford M, King P, et al. A pilot randomized trial of metacognitive therapy vs applied relaxation in the treatment of adults with generalized anxiety disorder. Behaviour Research and Therapy. 2010;48(5):429-34
48. Macleod C, Hagan R. Individual differences in the selective processing of threatening information, and emotional responses to a stressful life event. Behavioural Research and Therapy. 1992;30(2):151-61
49. Taylor L, Espie C, White C. Attentional Bias in People With Acute Versus Persistent Insomnia Secondary to Cancer. Behav Sleep Med. 2003;1(4):200-12
50. Chan MW, Ho SM, Tedeschi RG, et al. The valence of attentional bias and cancer-related rumination in posttraumatic stress and posttraumatic growth among women with breast cancer. Psychooncology. 2011;20(5):544-52
51. Hayes S, Strohsahl K, Wilson K. Acceptance and Commitment Therapy; An experiential approach to behaviour change. New York: Guildford Press; 2003
52. Fletcher L, Hayes S. Relational frame theory, acceptance and commitment therapy, and a functional analytic definition of mindfulness. Journal of Rational-Emotive and Cognitive-Behavior Therapy. 2005;23(4):315-36
53. Hulbert-Williams N, Storey L, Wilson K. The Potential Utility of Acceptance and Commitment Therapy (ACT) in Psychosocial Oncology. 12th World Congress of the International PsychoOncology Society (IPOS) Quebec City, QC, Canada. 2010
54. Rost AD, Wilson K, Buchanan E, et al. Improving Psychological Adjustment Among Late-Stage Ovarian Cancer Patients: Examining the Role of Avoidance in Treatment. Cognitive and Behavioral Practice. 2012;19(4):508-17
55. Feros DL, Lane L, Ciarrochi J, et al. Acceptance and Commitment Therapy (ACT) for improving the lives of cancer patients: a preliminary study. Psychooncology. 2013;22(2):459-64.
56. Humphries G, Rogers S. AFTER and beyond: cancer recurrence fears and test of an intervention in oropharyngeal patients. Social Science and Dentistry. 2012;2(1):29-38
57. Humphris GM, Ozackinci G. The AFTER intervention: A structured psychological approach to reduce fears of recurrence in patients with head and neck cancer. British Journal of Health Psychology. 2008;13(2):223-30
58. Kissane DW, Bloch S, Miach P, Smith GC, Seddon A, Keks N. Cognitive-existential group therapy for patients with primary breast cancer-Techniques and themes. Psycho-Oncology. 1997;6(1):25-33.
59. Herschbach P, Book K, Dinkel A, et al. Evaluation of two group therapies to reduce fear of progression in cancer patients. Support Care Cancer. 2010;18(4):471-9
60. Sabariego C, Brach M, Herschbach P, et al. Cost-effectiveness of cognitive-behavioral group therapy for dysfunctional fear of progression in cancer patients. The European Journal of Health Economics. 2010.
61. Heinrichs N, Zimmermann T, Huber B, et al. Cancer distress reduction with a couple-based skills training: A randomized controlled trial. Ann Behav Med. 2012;43(2):239-52
62. Chambers SK, Foley E, Galt E, et al. Mindfulness groups for men with advanced prostate cancer: a pilot study to assess feasibility and effectiveness and the role of peer support. Support Care Cancer. 2012;20(6):1183-92
63. Lengacher C, Jonhson-Mallard V, Post-White J, et al. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psychooncology. 2009;18(12):1261-72
64. Lengacher CA, Johnson-Mallard V, Barta M, et al. Feasibility of a Mindfulness-Based Stress Reduction Program for Early-Stage Breast Cancer Survivors. J Holist Nurs. 2011;29(2):107-17
65. Lengacher CA, Shelton MM, Reich RR, et al. Mindfulness based stress reduction (MBSR(BC)) in breast cancer: Evaluating fear of recurrence (FOR) as a mediator of psychological and physical symptoms in a randomized control trial (RCT). J Behav Med. 2014;37(2):185-95
66. Dieng M, Cust A, Morton R, et al. A Randomised Controlled Trial of a Psycho-Educational Intervention for Melanoma Survivors at High Risk of Developing New Primary Disease. 15th World Congress of Psycho-Oncology, 4-8 November 2013. Rotterdam, The Netherlands. Psychooncology. 2013;22(Suppl. 3):75